| # | Drug | Count |
|---|---|---|
| 0 | LETROZOLE | 20 |
| 1 | LETROZOLE TABLETS | 20 |
| 2 | RIBOCICLIB | 18 |
| 3 | OCRELIZUMAB | 16 |
| 4 | FULVESTRANT | 15 |
| 5 | OMEPRAZOLE MAGNESIUM | 15 |
| 6 | CALCIUM | 14 |
| 7 | CARVEDILOL | 14 |
| 8 | ERGOCALCIFEROL | 14 |
| 9 | METHOTREXATE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PASSIFLORA INCARNATA, IGNATIA AMARA, VALERIANA OFFICINALIS | 1 | 0.0833 |
| 1 | PROBENECID | 5 | 0.0042 |
| 2 | IBANDRONATE SODIUM | 9 | 0.0029 |
| 3 | ALFUZOSIN HYDROCHLORIDE | 4 | 0.0016 |
| 4 | BRINZOLAMIDE | 8 | 0.0009 |
| 5 | TELMISARTAN | 13 | 0.0007 |
| 6 | CIDOFOVIR ANHYDROUS | 1 | 0.0007 |
| 7 | TALQUETAMAB-TGVS | 1 | 0.0007 |
| 8 | BARICITINIB | 2 | 0.0007 |
| 9 | SENNOSIDES A AND B | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 25 |
| 1 | Corticosteroid [EPC] | 24 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 3 | Aromatase Inhibitor [EPC] | 20 |
| 4 | Proton Pump Inhibitor [EPC] | 17 |
| 5 | beta-Adrenergic Blocker [EPC] | 16 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 15 |
| 7 | Atypical Antipsychotic [EPC] | 15 |
| 8 | Estrogen Receptor Antagonist [EPC] | 15 |
| 9 | Calcium [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cannabinoid [EPC] | 4 | 0.0005 |
| 1 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 2 | Carbonic Anhydrase Inhibitor [EPC] | 8 | 0.0004 |
| 3 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 4 | Estrogen Receptor Antagonist [EPC] | 15 | 0.0004 |
| 5 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 5 | 0.0002 |
| 6 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0002 |
| 8 | GLP-2 Analog [EPC] | 3 | 0.0002 |
| 9 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |